The gynaecological management of women on tamoxifen: A national questionnaire survey

Journal of Obstetrics and Gynaecology

Volumn 24, Issue 6, 2004, Pages 675-679

  Brockbank, E C ^a,c   Ghaem Maghami, S ^b   Bridges, J E ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CARCINOMA; DRUG USE; ENDOMETRIUM BIOPSY; FEMALE; HEALTH SURVEY; HUMAN; IMAGE ANALYSIS; PELVIS; POSTAL MAIL; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; ULTRASOUND; UNITED KINGDOM;

BIOPSY; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GYNECOLOGY; HUMANS; POSTMENOPAUSE; QUESTIONNAIRES; TAMOXIFEN;

EID: 10644240809     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610400008016     Document Type: Review

References (28)

1. Altaras M., Aviram R., Cohen C., Markov S., Goldbern G. and Beyth Y. (1993) Microhysteroscopy and endometrial biopsy results following failed dilation and curettage in women with postmenopausal bleeding. International Journal of Gynaecology and Obstetrics, 42, 255-260.
2. Barakat R.R., Wong G., Curtin J.P., Vlamis V. and Hoskins W.J. (1994) Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecologic Oncology, 55, 164-168.
3. Bergman L., Beelen M.L., Gallee M.P., Hollema H., Benraadt J. and van Leeuwen F.E. (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial Cancer Risk following Tamoxifen. Lancet, 356, 881-887.
4. Clark T.J., Mann C.H., Shah N., Khan K.S., Song F. and Gupta J.K. (2002) Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. British Journal of Obstetrics and Gynaecology, 109, 313-321.
5. Cohen C., Azaria R., Aviram R., Bernheim J., Tepper R., Cordoba M. and Beyth Y. (1999) Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings. Gynecologic and Obstetric Investigation, 48 187-192.
6. Early Breast Cancer Trialists' Collaborative Group. (1998) tamoxifen for early breast cancer: an overview of the randomised trials. Lancet, 352, 1451-1467.
7. Fisher B., Costantino J., Redmond C., Poisson R., Bowman D., Couture J., Dimitrov N.V., Wolmark N., Wickerham D.L. and Fisher E.R. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. New England Journal of Medicine, 320, 479-484.
8. Fisher B., Costantino J.P., Redmond C.K., Fisher E.R., Wickerham D.L. and Cronin W.M. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Journal of the National Cancer Institute, 86, 527-537.
9. Fornander T., Rutqvist L.E., Cedermark B., Glas U., Mattsson A., Silfversward C., Skoog L., Somell A., Theve T. and Wilking U. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet, 1, 117-120.
10. Gimpelson R. and Rappold H. (1988) A comparative study between panoramic hysteroscopy with directed biopsies and dilation and curettage. American Journal of Obstetrics and Gynecology, 158, 489-492.
11. Hoffken K. (2001) The European experience. Journal of Clinical Oncology, 19, 112S-117S.
12. Ismail S.M. (1994) Pathology of endometrium treated with tamoxifen. Journal of Clinical Pathology, 47, 827-833.
13. Kedar R.P., Bourne T.H., Powles T.J., Collins W.P., Ashley S.E., Cosgrove D.O. and Campbell S. (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet, 343, 1318-1321.
14. Killackey M.A., Hakes T.B. and Pierce V.K. (1985) Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treatment Reports, 69, 237-238.
15. Lahti E., Blanco G., Kauppila A., Apaja-Sarkkinen M., Taskinen P.J. and Laatikainen T. (1993) Endometrial change sin postmenopausal breast cancer patients receiving tamoxifen. Obstetrics and Gynecology, 81, 660-664.
16. Loffer F.D. (1989) Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view. Obstetrics and Gynecology, 73, 16-20.
17. Love C.D., Muir B.B., Scrimgeour J.B., Leonard R.C., Dillon P. and Dixon J.M. (1999) Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. Journal of Clinical Oncology, 17, 2050-2054.
18. Neven P., De Muylder X., Van Belle Y., Vanderick G. and De Muylder E. (1989) Tamoxifen and the uterus and the endometrium. Lancet, 375, 376.
19. Neven P., De Muylder X. and Yen Belle Y. (1997) Tamoxifen-induced endometrial polyp. New England Journal of Medicine, 336, 1389.
20. O'Brien P.M.S. and MacLean A.B. (1999) Hormones and Cancer. London, RCOG Press.
21. Powles T.J., Hardy J.R., Ashley S.E., Farrington G.M., Cosgrove D., Davey J.B., Dowsett M., McKinna J.A., Nash A.G. and Sinnett H.D. (1989) A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. British Journal of Cancer, 60, 126-131.
22. Powles T.J., Tillyer C.R., Jones A.L., Ashley S.E., Treleaven J., Davey J.B. and McKinna J.A. (1990) Prevention of breast cancer with tamoxifen - an update on the Royal Marsden Hospital pilot programme. European Journal of Cancer, 26, 680-684.
23. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J. and Scanlan T.S. (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science, 277, 1508-1510.
24. Iberia G. and Swindell R. (1988) The Christie Hospital adjuvant tamoxifen trial - status at 10 years. British Journal of Cancer, 57, 601-603.
25. Iberia G. and Swindell R. (1992) The Christie Hospital adjuvant tamoxifen trial. Journal of the National Cancer Institute Monographs, 11, 121-125.
26. Stovall T.G., Photopulos G.J., Poston W.M., Ling F.W. and Sandles L.G. (1991) Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstetrics and Gynecology, 77, 954-956.
27. Sunderland M.C. and Osborne C.K. (1991) Tamoxifen in premenopausal patients with metastatic breast cancer: a review. Journal of Clinical Oncology, 9, 1283-1297.
28. Towbin N.A., Gviazda I.M. and March C.M. (1996) Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. American Journal of Obstetrics and Gynecology, 174, 1678-1682.